Citius Pharmaceuticals Inc (CTXR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 8,672 | 10,685 | 7,250 | 7,550 | 8,917 |
| Operating Income | -8,672 | -10,685 | -7,250 | -7,550 | -8,917 |
| Other Income | 337 | 303 | 3,800 | 135 | 53 |
| Pre-tax Income | -8,335 | -10,382 | -3,450 | -7,415 | -8,864 |
| Income Tax | 144 | 144 | 144 | N/A | 0 |
| Net Income Continuous | -8,479 | -10,526 | -3,594 | -7,991 | -8,864 |
| Net Income | $-8,479 | $-10,526 | $-3,594 | $-7,991 | $-8,864 |
| EPS Basic Total Ops | -1.50 | -1.75 | -0.50 | -1.50 | -1.50 |
| EPS Basic Continuous Ops | -1.38 | -1.80 | -0.61 | -1.37 | -1.52 |
| EPS Diluted Total Ops | -1.50 | -1.75 | -0.50 | -1.50 | -1.50 |
| EPS Diluted Continuous Ops | -1.38 | -1.80 | -0.61 | -1.37 | -1.52 |
| EBITDA(a) | $-8,623 | $-10,637 | $-7,203 | $-7,503 | $-8,871 |